These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2101484)

  • 1. Recombinant BCG as a candidate oral vaccine vector.
    Barletta RG; Snapper B; Cirillo JD; Connell ND; Kim DD; Jacobs WR; Bloom BR
    Res Microbiol; 1990; 141(7-8):931-9. PubMed ID: 2101484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
    Fuerst TR; Stover CK; de la Cruz VF
    Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
    DasGupta SK; Jain S; Kaushal D; Tyagi AK
    Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New use of BCG for recombinant vaccines.
    Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF
    Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.
    Oliveira TL; Rizzi C; Dellagostin OA
    Appl Microbiol Biotechnol; 2017 Sep; 101(18):6865-6877. PubMed ID: 28779291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
    Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
    Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant BCG as a vaccine vehicle to protect against tuberculosis.
    Triccas JA
    Bioeng Bugs; 2010; 1(2):110-5. PubMed ID: 21326936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG.
    Seixas FK; Borsuk S; Fagundes MQ; Hartwig DD; Da Silva EF; Cerqueira GM; Dellagostin OA
    Biol Res; 2010; 43(1):13-8. PubMed ID: 21157628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of genetic systems for the mycobacteria.
    Jacobs WR; Snapper SB; Lugosi L; Jekkel A; Melton RE; Kieser T; Bloom BR
    Acta Leprol; 1989; 7 Suppl 1():203-7. PubMed ID: 2503991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.
    Dietrich G; Viret JF; Hess J
    Vaccine; 2003 Jan; 21(7-8):667-70. PubMed ID: 12531337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant BCG as an antigen delivery system.
    Flynn JL
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():31-6. PubMed ID: 7950859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial vaccine vectors and bacillus Calmette-Guérin.
    Cirillo JD; Stover CK; Bloom BR; Jacobs WR; Barletta RG
    Clin Infect Dis; 1995 Apr; 20(4):1001-9. PubMed ID: 7795044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
    Aldovini A; Young RA
    Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new series of mycobacterial expression vectors for the development of live recombinant vaccines.
    Baulard A; Kremer L; Supply P; Vidaud D; Bidart JM; Bellet D; Locht C
    Gene; 1996 Oct; 176(1-2):149-54. PubMed ID: 8918246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of BCG vaccine: a double-edged sword.
    Singh VK; Srivastava R; Srivastava BS
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
    Nieuwenhuizen NE; Kaufmann SHE
    Front Immunol; 2018; 9():121. PubMed ID: 29459859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis.
    Dhar N; Rao V; Tyagi AK
    FEMS Microbiol Lett; 2000 Sep; 190(2):309-16. PubMed ID: 11034297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery.
    Hanson MS; Lapcevich CV; Haun SL
    Ann N Y Acad Sci; 1995 May; 754():214-21. PubMed ID: 7625654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.